Business Description
Medicus Pharma Ltd. is a biotech company based in Conshohocken, Pennsylvania, working to bring new treatments to patients in the United States. Its lead program, SKNJCT-003, is currently in Phase 2 clinical trials as a potential treatment for basal cell carcinoma, a common form of skin cancer. The company has partnered with the Gorlin Syndrome Alliance to expand patient access to its SKINJECT therapy for those living with Gorlin Syndrome.
